#Stratipath
LightNews LightNews
4040rec.bsky.social
#cancerdiagnostics #diagnostics #AIdiagnostics #personalisedcancerdiagnostics #precisiondiagnostics #Diagnexia #Stratipath #AIbreastcancerdiagnostics #breastcancerdiagnostics #AIbasedriskprofilingtools #StratipathBreast #precisecancerdiagnostics #precisiononcology
pharmatimes.com/news/diagnex...
Diagnexia and Stratipath link up brings AI breast cancer diagnostics to UK - PharmaTimes
Collaboration expands AI-based risk profiling tools
pharmatimes.com
April 2, 2025 at 11:53 AM
stratipath.bsky.social
Stratipath Breast is the first CE-IVD, AI-based prognostic risk profiling tool. It analyses cancer tissue, enabling the identification of either an increased or a low risk of disease progression. It is in clinical use and validated in large-scale studies. www.stratipath.com/stratipath-b...
June 13, 2025 at 9:22 AM
kwiatberlin.bsky.social
PathAI Expands Clinical Leadership - Announcing Partnerships with Mindpeak, Stratipath, and Primaa

www.globenewswire.com/news-release...
PathAI Expands Clinical Leadership - Announcing Partnerships with Mindpeak, Stratipath, and Primaa
BOSTON, Sept. 04, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered digital pathology solutions and the developer of the market-leading...
www.globenewswire.com
September 4, 2025 at 5:04 PM
360dx.bsky.social
www.360dx.com/cancer/strat...
Stratipath, Aiforia Partner for AI-Based Breast Cancer Diagnostic Development
The firms will integrate their technologies into a single workflow and jointly engage in initiatives to raise awareness of AI-based precision oncology testing.
www.360dx.com
August 25, 2026 at 2:26 PM
genial-project.bsky.social
Stratipath (Sweden) is a crucial part of the GENIAL Project, with the mission to advance AI-powered solutions for precision medicine and cancer research. 🌍✨

Learn more 👉 genial-project.com
| www.stratipath.com

#AI #CancerResearch #PrecisionMedicine #EUProjects
September 11, 2025 at 8:00 AM
360dx.bsky.social
www.360dx.com/cancer/strat...
Stratipath Nabs CE-IVDR Marking for AI-Enabled Breast Cancer Risk Profiling Test
The test has been in routine clinical use since 2023 and returns results within one hour, the company noted.
www.360dx.com
June 17, 2026 at 12:09 AM
longtail-news.bsky.social
Feed: "PharmaTimes"
By: John Pinching on Tuesday, April 1, 2025
Diagnexia and Stratipath link up brings AI breast cancer diagnostics to UK
Collaboration expands AI-based risk profiling tools
pharmatimes.com
April 1, 2025 at 9:07 PM
d-and-d-world.bsky.social
Stratipath and PathAI join forces to expand global access to AI-powered breast cancer diagnostics through AISight Dx. Faster, scalable, and more equitable care.
#News #AI #CancerDiagnostics #BreastCancer #DigitalPathology #HealthcareInnovation
Stratipath and PathAI partner to advance AI cancer diagnostics
Partnership integrates Stratipath Breast into PathAI’s AISight Dx, expanding global access to rapid AI-based cancer diagnostics.
druganddeviceworld.com
September 4, 2025 at 7:38 PM
medrxivpreprint.bsky.social
Validation of an AI-based solution for breast cancer risk stratification using routine digital histopathology images https://www.medrxiv.org/content/10.1101/2023.10.10.23296761v1
Validation of an AI-based solution for breast cancer risk stratification using routine digital histopathology images https://www.medrxiv.org/content/10.1101/2023.10.10.23296761v1
Background Stratipath Breast is a CE-IVD marked artificial intelligence-based solution for prognosti
www.medrxiv.org
October 11, 2023 at 2:10 AM
phalguniddw.bsky.social
Stratipath and PathAI join forces to expand global access to AI-powered breast cancer diagnostics through AISight Dx. Faster, scalable, and more equitable care.
#News #AI #CancerDiagnostics #BreastCancer #DigitalPathology #HealthcareInnovation
Stratipath and PathAI partner to advance AI cancer diagnostics
Partnership integrates Stratipath Breast into PathAI’s AISight Dx, expanding global access to rapid AI-based cancer diagnostics.
druganddeviceworld.com
September 4, 2025 at 7:38 PM
stratipath.bsky.social
Linköping University Hospital and Region Östergötland have chosen to implement AI-based Stratipath Breast as part of their clinical routine for breast cancer diagnostics.
“We have high expectations for what it could bring to our clinical workflow.” / Pathologist
www.stratipath.com/ostergotland...
Region Östergötland Implements AI-Powered Stratipath Breast to Enhance Breast Cancer Diagnostics – Stratipath
Linköping University Hospital and Region Östergötland have chosen to implement Stratipath Breast as part of their clinical routine for early breast cancer diagnostics.
www.stratipath.com
June 17, 2025 at 9:18 AM
stratipath.bsky.social
Article in ”Oncology in Sweden” on the continuation of SwAIPP (Sweden AI Precision Pathology)
www.stratipath.com/article-in-o...
Article in ”Oncology in Sweden” on the continuation of SwAIPP (Sweden AI Precision Pathology) – Stratipath
SwAIPP 2, the continuation of the SwAIPP project, has been funded by Sweden’s innovation agency, Vinnova. We at Stratipath are proud to be partners in this consortium alongside leaders in academia, he...
www.stratipath.com
June 13, 2025 at 9:36 AM
stratipath.bsky.social
Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic solution, Stratipath Breast. www.stratipath.com/stratipath-r...
Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic solution, Stratipath Breast – Stratipath
Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic solution, Stratipath Breast. The new capability strengthens clinical decision-making for neoadjuvant therapy.
www.stratipath.com
June 13, 2025 at 9:35 AM
stratipath.bsky.social
Unilabs is implementing Stratipath Breast for enhanced breast cancer diagnostics at Capio S:t Göran’s Hospital. www.stratipath.com/unilabs-is-i...
Unilabs is implementing Stratipath Breast for enhanced breast cancer diagnostics at Capio S:t Göran’s Hospital – Stratipath
Capio St Göran’s Hospital is one of the largest breast cancer clinics in Sweden treating more than 600 breast cancer patients annually. With this new collaboration, Unilabs will use Stratipath Breast ...
www.stratipath.com
June 13, 2025 at 9:35 AM
stratipath.bsky.social
Stratipath is proud to announce that globally recognized breast oncologist, Professor Daniel F. Hayes, has joined the company’s Scientific Advisory Board. www.stratipath.com/daniel-hayes...
Professor Daniel Hayes Joins Stratipath’s Scientific Advisory Board – Stratipath
Stratipath is proud to announce that globally recognized breast oncologist, Professor Daniel F. Hayes, has joined the company’s Scientific Advisory Board. Professor Hayes will collaborate closely with...
www.stratipath.com
June 13, 2025 at 9:34 AM
stratipath.bsky.social
Region Uppsala, Sweden’s fourth largest healthcare region, has chosen to implement Stratipath Breast, an AI-based risk profiling solution for breast cancer, in clinical use. www.stratipath.com/region-uppsa...
Region Uppsala chooses to implement AI-based risk profiling with Stratipath Breast – Stratipath
Region Uppsala, Sweden’s fourth largest healthcare region, has chosen to implement Stratipath Breast, an AI-based risk profiling solution for breast cancer, in clinical use.
www.stratipath.com
June 13, 2025 at 9:33 AM